Acadia Pharmaceuticals (ACAD) Change in Inventory (2016 - 2026)

Acadia Pharmaceuticals' Change in Inventory history runs 11 years deep, the most recent figure standing at -$78000.0 for Q1 2026.

• On a quarterly basis, Change in Inventory fell 100.75% year-over-year to -$78000.0 in Q1 2026; TTM through Mar 2026 was $7.7 million, a 82.32% decrease from a year earlier, with the FY2025 full-year figure at $18.2 million, down 63.28% from the prior year.
• Change in Inventory slipped to -$78000.0 in Q1 2026 per ACAD's latest filing, from $4.9 million in the prior quarter.
• Across five years, Change in Inventory topped out at $27.1 million in Q2 2024 and bottomed at -$1.2 million in Q3 2025.
• The 5-year median for Change in Inventory is $3.0 million (2023), against an average of $5.5 million.
• Across the five-year window, Change in Inventory plunged 269.31% in 2022 and surged 4960.32% in 2023, its largest moves.
• Year by year, Change in Inventory stood at -$310000.0 in 2022, then jumped by 4960.32% to $15.1 million in 2023, then plunged by 70.64% to $4.4 million in 2024, then increased by 10.58% to $4.9 million in 2025, then sank by 101.59% to -$78000.0 in 2026.
• Per Business Quant, the three latest ACAD Change in Inventory figures stand at -$78000.0 (Q1 2026), $4.9 million (Q4 2025), and -$1.2 million (Q3 2025).